We are delighted to introduce you to Naved Malek, Audra Stinchcomb, Priyabrata Mukherjee, Wilson Poon, Emily Day and Anthony Hickey as part of our inaugural RSC Pharmaceutics Advisory Board!
Dr Naved Malek is an Associate Professor at the Ionic Liquids Research Laboratory in the Department of Chemistry at Sardar Vallabhbhai National Institute of Technology located in Surat, India.
“RSC journals come with scientific excellence, quality and are highly regarded across various scientific communities. RSC Pharmaceutics with its targeted audience can enhance the visibility and credibility of the work that meets high standards of scientific rigor and innovation in the field of drug delivery, formulation, and physicochemical and biological properties of drugs and their carriers.” – Professor Naved Malek
Professor Audra L. Stinchcomb is currently a Professor in the School of Pharmacy at the University of Maryland in Baltimore, USA.
“The Royal Society of Chemistry has a long history of high impact chemistry journals, so of course Pharmaceutics is an important addition to the collection. I am pleased to be part of a journal focused on transparent peer review and the scientists who make a difference in bringing the world quality pharmaceuticals.” – Professor Audra L. Stinchcomb
Professor Priyabrata Mukherjee is a PHF-Presidential Professor and a Professor of Pathology at University of Oklahoma Health Sciences Center. He is also a Peggy and Charles Stephenson Endowed Chair of Laboratory Cancer Research, Senior Director for Research Partnership and Collaboration at the Stephenson Cancer Center and Co-Director of the Nanomedicine Program.
Dr Wilson Poon is an Assistant Professor in the Department of Metallurgical, Materials and Biomedical Engineering at the University of Texas at El Paso
“I wanted to be involved with RSC Pharmaceutics because together, I think we can push the next generation of drug formulation and delivery science forward.”– Dr Wilson Poon
Dr Emily Day is currently an Associate Professor of Biomedical Engineering at the University of Delaware, in the USA.
“I am excited to support RSC Pharmaceutics as this journal will provide a venue for researchers to share their most exciting work at the leading edge of drug development and delivery.”- Dr Emily Day
Professor Anthony Hickey is Professor Emeritus in the Eshelman School of Pharmacy and Adjunct Professor in the Department of Biomedical Engineering of the School of Medicine of The University of North Carolina at Chapel Hill.
“RSC Pharmaceutics is a new forum addressing the demand for exchange of data, knowledge and ideas emerging from scientific and technological advances in novel therapeutic modalities, due to contemporary insights into the origins and mechanism of disease. Publications in the journal support the framework of understanding required to address the needs of disease therapy in the 21st Century.”- Professor Anthony Hickey
RSC Pharmaceutics is a new gold open access journal from the Royal Society of Chemistry and publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. This journal is open for submissions.
Check out our author guidelines for information on our article types or find out more about the advantages of publishing in a Royal Society of Chemistry journal.
Keep up to date with our latest news by following us on LinkedIn. You can also keep informed by signing up to our E-Alerts.